Welcome to Psychiatric Times' coverage of the 168th Annual Meeting of the American Psychiatric Association, May 16 to 18, 2015, with a focus on schizophrenia. See our other topic-specific pages:
APA: Bipolar DisorderAPA: Major Depressive Disorder
Marijuana—Legal, But Not by Prescription
What are the pros and cons of marijuana use? Dr Andrew Saxon gives his viewpoint on why he is against medical marijuana but in favor of legalization of recreational use of marijuana.
New Psychopharmacology Algorithms
Dr David Osser offers compelling reasons why you might want to take a look at these 7 algorithms, each of which offers actionable consultations—usually in under 2 minutes.
Subtle Nuances in Diagnosis of Schizophrenia
An analysis of symptom severity across domains may enable us to reevaluate how we categorize symptoms within the spectrum of psychotic illness.
Schizophrenia: It’s Not Just About Dopamine
Physicians recognize many features of schizophrenia, but one neglected area is the common symptom of a poor self-other boundary—in fact, this has also been neglected as a criterion for the DSM.
Schizophrenic Disorders: Is There an Elephant?
Multiple perspectives are required to fully understand a concept. This seems to be the growing consensus with the schizophrenia spectrum disorders.
Take Home Lessons on Schizophrenia
If the models in this discussion are disseminated and used, costs will drop and patients will enjoy an improved quality of life.
What’s New About Schizophrenia?
“Those who fail to learn from the mistakes of their predecessors are destined to repeat them.” This may be the take-home point of the APA 2015 meeting regarding schizophrenia.
Earn CME Credits for reading Psychiatric Times articles. Click here to go to our free online CME activities.
By clicking Accept, you agree to become a member of the UBM Medica Community.